{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:21:32Z","timestamp":1792689692999,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00894-017-3548-9","type":"journal-article","created":{"date-parts":[[2018,1,13]],"date-time":"2018-01-13T06:44:26Z","timestamp":1515825866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Similarity search combined with docking and molecular dynamics for novel hAChE inhibitor scaffolds"],"prefix":"10.1007","volume":"24","author":[{"given":"Nadia Melo","family":"Borges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldo Rodrigues","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean F. R.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josmar R.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o B. L.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Gargano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,13]]},"reference":[{"key":"3548_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1474-4422(03)00502-7","volume":"2","author":"E Scarpini","year":"2003","unstructured":"Scarpini E, Schelterns P, Feldman H (2003) Treatment of Alzheimer\u2019s disease; current status and new perspectives. Lancet Neurol 2:539\u2013547. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(03)00502-7","journal-title":"Lancet Neurol"},{"key":"3548_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM Mckhann","year":"2011","unstructured":"Mckhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement 7:263\u2013269. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimers Dement"},{"key":"3548_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jalz.2011.04.002","volume":"7","author":"K Herrup","year":"2011","unstructured":"Herrup K (2011) Commentary on \u201crecommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.\u201d addressing the challenge of Alzheimer\u2019s disease in the 21st century. Alzheimers Dement 7:335\u2013337. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2011.04.002","journal-title":"Alzheimers Dement"},{"key":"3548_CR4","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/nn940","volume":"5","author":"M Citron","year":"2002","unstructured":"Citron M (2002) Alzheimer\u2019s disease: treatments in discovery and development. Nat Neurosci 5:1055\u20131057. \n                    https:\/\/doi.org\/10.1038\/nn940","journal-title":"Nat Neurosci"},{"key":"3548_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1756285612461679","volume":"6","author":"KG Yiannopoulou","year":"2013","unstructured":"Yiannopoulou KG, Papageorgiou SG (2013) Current and future treatments for Alzheimer\u2019s disease. Ther Adv Neurol Disord 6:19\u201333. \n                    https:\/\/doi.org\/10.1177\/1756285612461679","journal-title":"Ther Adv Neurol Disord"},{"key":"3548_CR6","doi-asserted-by":"publisher","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a006189","DOI":"10.1101\/cshperspect.a006189"},{"key":"3548_CR7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","volume":"88","author":"C Reitz","year":"2014","unstructured":"Reitz C, Mayeux R (2014) Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol 88:640\u2013651. \n                    https:\/\/doi.org\/10.1016\/j.bcp.2013.12.024","journal-title":"Biochem Pharmacol"},{"key":"3548_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","volume":"66","author":"PT Francis","year":"1999","unstructured":"Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress. J Neurol Neurosurg Psychiatry 66:137\u2013147. \n                    https:\/\/doi.org\/10.1136\/jnnp.66.2.137","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3548_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/oxfordjournals.bmb.a072100","volume":"42","author":"EK Perry","year":"1986","unstructured":"Perry EK (1986) The cholinergic hypothesis\u2014ten years on. Br Med Bull 42:63\u201369. \n                    https:\/\/doi.org\/10.1093\/OXFORDJOURNALS.BMB.A072100","journal-title":"Br Med Bull"},{"key":"3548_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.pbb.2011.02.022","volume":"99","author":"JA Dumas","year":"2011","unstructured":"Dumas JA, Newhouse PA (2011) The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation. Pharmacol Biochem Behav 99:254\u2013261. \n                    https:\/\/doi.org\/10.1016\/j.pbb.2011.02.022","journal-title":"Pharmacol Biochem Behav"},{"key":"3548_CR11","doi-asserted-by":"publisher","first-page":"17843","DOI":"10.1021\/ja905457d","volume":"131","author":"N Miyashita","year":"2009","unstructured":"Miyashita N, Straub JE, Thirumalai D (2009) Structures of beta-amyloid peptide 1-40, 1-42, and 1-55-the 672-726 fragment of APP-in a membrane environment with implications for interactions with gamma-secretase. J Am Chem Soc 131:17843\u201317852. \n                    https:\/\/doi.org\/10.1021\/ja905457d","journal-title":"J Am Chem Soc"},{"key":"3548_CR12","doi-asserted-by":"crossref","unstructured":"Gallagher D, Coen RF, Lawlor BA (2016) Alzheimer disease. In: Hardiman O, Doherty CP, Elamin M, Bede P (eds)Neurodegenerative disorders:a clinical guide. Springer, Berlin, pp\u00a057\u201374","DOI":"10.1007\/978-3-319-23309-3_4"},{"key":"3548_CR13","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1021\/cr300009x","volume":"112","author":"KP Kepp","year":"2012","unstructured":"Kepp KP (2012) Bioinorganic chemistry of Alzheimer\u2019s disease. Chem Rev 112:5193\u20135239. \n                    https:\/\/doi.org\/10.1021\/cr300009x","journal-title":"Chem Rev"},{"key":"3548_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jalz.2010.03.016","volume":"7","author":"G Small","year":"2011","unstructured":"Small G, Bullock R (2011) Defining optimal treatment with cholinesterase inhibitors in Alzheimer\u2019s disease. Alzheimers Dement 7:177\u2013184. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2010.03.016","journal-title":"Alzheimers Dement"},{"key":"3548_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","volume":"36","author":"P Anand","year":"2013","unstructured":"Anand P, Singh B (2013) A review on cholinesterase inhibitors for Alzheimer\u2019s disease. Arch Pharm Res 36:375\u2013399. \n                    https:\/\/doi.org\/10.1007\/s12272-013-0036-3","journal-title":"Arch Pharm Res"},{"key":"3548_CR16","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1021\/bi400442d","volume":"52","author":"HY Qureshi","year":"2013","unstructured":"Qureshi HY, Li T, MacDonald R et al (2013) Interaction of 14-3-3\u03b2 with microtubule-associated protein tau within alzheimer\u2019s disease neurofibrillary tangles. Biochemistry 52:6445\u20136455. \n                    https:\/\/doi.org\/10.1021\/bi400442d","journal-title":"Biochemistry"},{"key":"3548_CR17","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/qua.24341","volume":"113","author":"AS Kiametis","year":"2013","unstructured":"Kiametis AS, Martins JBL, Romeiro LAS, Gargano R (2013) Acetylcholinesterase inhibitors: modeling potential candidates. Int J Quantum Chem 113:1461\u20131466. \n                    https:\/\/doi.org\/10.1002\/qua.24341","journal-title":"Int J Quantum Chem"},{"key":"3548_CR18","doi-asserted-by":"publisher","unstructured":"Kiametis AS, Silva MA, Romeiro LAS et al (2017) Potential acetylcholinesterase inhibitors: molecular docking, molecular dynamics, and in silico prediction. J Mol Model 23(2):67. \n                    https:\/\/doi.org\/10.1007\/s00894-017-3228-9","DOI":"10.1007\/s00894-017-3228-9"},{"key":"3548_CR19","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00894-010-0838-x","volume":"17","author":"ECM Nascimento","year":"2011","unstructured":"Nascimento ECM, Martins JBL (2011) Electronic structure and PCA analysis of covalent and non-covalent acetylcholinesterase inhibitors. J Mol Model 17:1371\u20131379","journal-title":"J Mol Model"},{"key":"3548_CR20","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1016\/j.ejmech.2009.03.045","volume":"44","author":"AAN Paula De","year":"2009","unstructured":"De Paula AAN, Martins JBL, dos Santos ML et al (2009) New potential AChE inhibitor candidates. Eur J Med Chem 44:3754\u20133759","journal-title":"Eur J Med Chem"},{"key":"3548_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cplett.2008.05.006","volume":"458","author":"ECM Nascimento","year":"2008","unstructured":"Nascimento ECM, Martins JBL, dos Santos ML, Gargano R (2008) Theoretical study of classical acetylcholinesterase inhibitors. Chem Phys Lett 458:285\u2013289","journal-title":"Chem Phys Lett"},{"key":"3548_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cplett.2007.08.055","volume":"446","author":"AAN Paula De","year":"2007","unstructured":"De Paula AAN, Martins JBL, Gargano R et al (2007) Electronic structure calculations toward new potentially AChE inhibitors. Chem Phys Lett 446:304\u2013308. \n                    https:\/\/doi.org\/10.1016\/j.cplett.2007.08.055","journal-title":"Chem Phys Lett"},{"key":"3548_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.neulet.2015.12.021","volume":"612","author":"J Misik","year":"2016","unstructured":"Misik J, Korabecny J, Nepovimova E et al (2016) Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats-is there a potential for Alzheimer\u2019s disease treatment? Neurosci Lett 612:261\u2013268. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2015.12.021","journal-title":"Neurosci Lett"},{"key":"3548_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1570159X11311030006","volume":"11","author":"MB Colovic","year":"2013","unstructured":"Colovic MB, Krstic DZ, Lazarevic-Pasti TD et al (2013) Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol 11:315\u2013335. \n                    https:\/\/doi.org\/10.2174\/1570159X11311030006","journal-title":"Curr Neuropharmacol"},{"key":"3548_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejphar.2007.06.053","volume":"572","author":"F Cerbai","year":"2007","unstructured":"Cerbai F, Giovannini MG, Melani C et al (2007) N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine. Eur J Pharmacol 572:142\u2013150. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2007.06.053","journal-title":"Eur J Pharmacol"},{"key":"3548_CR26","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/ci3001277","volume":"52","author":"JJ Irwin","year":"2012","unstructured":"Irwin JJ, Sterling T, Mysinger MM et al (2012) ZINC: a free tool to discover chemistry for biology. J Chem Inf Model 52:1757\u20131768. \n                    https:\/\/doi.org\/10.1021\/ci3001277","journal-title":"J Chem Inf Model"},{"key":"3548_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1021\/jm0603365","volume":"50","author":"PCD Hawkins","year":"2007","unstructured":"Hawkins PCD, Skillman AG, Nicholls A (2007) Comparison of shape-matching and docking as virtual screening tools. J Med Chem 50:74\u201382. \n                    https:\/\/doi.org\/10.1021\/jm0603365","journal-title":"J Med Chem"},{"key":"3548_CR28","unstructured":"ROCS (2015) 3.2.0.4: Openeye Scientific Software, Santa Fe, NM"},{"key":"3548_CR29","unstructured":"EON (2013) 2.2.0.5: OpenEye Scientific Software, Santa Fe, NM"},{"key":"3548_CR30","unstructured":"Glide (2009) Schrodinger, LLC, New York, NY"},{"key":"3548_CR31","unstructured":"Case DA, Babin V, Berryman JT et al (2014) AMBER14. San Francisco, CA"},{"key":"3548_CR32","doi-asserted-by":"publisher","unstructured":"Gaulton A, Bellis LJ, Bento AP et al (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40(Database issue):D1100\u2013D1107 \n                    https:\/\/doi.org\/10.1093\/nar\/gkr777","DOI":"10.1093\/nar\/gkr777"},{"key":"3548_CR33","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55:6582\u20136594. \n                    https:\/\/doi.org\/10.1021\/jm300687e","journal-title":"J Med Chem"},{"key":"3548_CR34","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.drudis.2014.10.012","volume":"20","author":"A Lavecchia","year":"2015","unstructured":"Lavecchia A (2015) Machine-learning approaches in drug discovery: methods and applications. Drug Discov Today 20:318\u2013331. \n                    https:\/\/doi.org\/10.1016\/j.drudis.2014.10.012","journal-title":"Drug Discov Today"},{"key":"3548_CR35","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.2174\/09298673113209990001","volume":"20","author":"A Lavecchia","year":"2013","unstructured":"Lavecchia A, Di Giovanni C (2013) Virtual screening strategies in drug discovery: a critical review. Curr Med Chem 20:2839\u20132860. \n                    https:\/\/doi.org\/10.2174\/09298673113209990001","journal-title":"Curr Med Chem"},{"key":"3548_CR36","unstructured":"ChemAxon (2013) Marvin sketch. In: \n                    https:\/\/www.chemaxon.com\/products\/marvin\/"},{"key":"3548_CR37","unstructured":"OMEGA (2013) 2.5.1.4: OpenEye Scientific Software, Santa Fe, NM"},{"key":"3548_CR38","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1021\/ci300314k","volume":"52","author":"PCD Hawkins","year":"2012","unstructured":"Hawkins PCD, Nicholls A (2012) Unknown_Conformer generation with OMEGA learning from the data set and the analysis of failures(3). J Chem Inf Model 52:2919\u20132936. \n                    https:\/\/doi.org\/10.1021\/ci300314k","journal-title":"J Chem Inf Model"},{"key":"3548_CR39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bmc.2012.10.045","volume":"21","author":"M Catto","year":"2013","unstructured":"Catto M, Pisani L, Leonetti F et al (2013) Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase. Bioorg Med Chem 21:146\u2013152. \n                    https:\/\/doi.org\/10.1016\/j.bmc.2012.10.045","journal-title":"Bioorg Med Chem"},{"key":"3548_CR40","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/cmdc.201000523","volume":"6","author":"C Ronco","year":"2011","unstructured":"Ronco C, Foucault R, Gillon E et al (2011) New huprine derivatives functionalized at position9 as highly potent acetylcholinesterase inhibitors. ChemMedChem 6:876\u2013888. \n                    https:\/\/doi.org\/10.1002\/cmdc.201000523","journal-title":"ChemMedChem"},{"key":"3548_CR41","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nrd1549","volume":"3","author":"DB Kitchen","year":"2004","unstructured":"Kitchen DB, Decornez H, Furr JR, Bajorath J (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 3:935\u2013949. \n                    https:\/\/doi.org\/10.1038\/nrd1549","journal-title":"Nat Rev Drug Discov"},{"key":"3548_CR42","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.4155\/fmc-2016-0143","volume":"8","author":"G Wang","year":"2016","unstructured":"Wang G, Zhu W (2016) Molecular docking for drug discovery and development: a widely used approach but far from perfect. Future Med Chem 8:1707\u20131710. \n                    https:\/\/doi.org\/10.4155\/fmc-2016-0143","journal-title":"Future Med Chem"},{"key":"3548_CR43","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"X-Y Meng","year":"2011","unstructured":"Meng X-Y, Zhang H-X, Mezei M, Cui M (2011) Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 7:146\u2013157. \n                    https:\/\/doi.org\/10.2174\/157340911795677602","journal-title":"Curr Comput Aided Drug Des"},{"key":"3548_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z et al (2000) The protein data bank. Nucleic Acids Res 28:235\u2013242. \n                    https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res"},{"key":"3548_CR45","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0969-2126(99)80040-9","volume":"7","author":"G Kryger","year":"1999","unstructured":"Kryger G, Silman I, Sussman JL (1999) Structure of acetylcholinesterase complexed with E2020 (Aricept??): implications for the design of new anti-Alzheimer drugs. Structure 7:297\u2013307. \n                    https:\/\/doi.org\/10.1016\/S0969-2126(99)80040-9","journal-title":"Structure"},{"key":"3548_CR46","unstructured":"Schr\u00f6dinger (2009) Protein preparation wizard.Schr\u00f6dinger, LLC, New York, NY"},{"key":"3548_CR47","doi-asserted-by":"publisher","unstructured":"Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA (2004) PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. \n                    https:\/\/doi.org\/10.1093\/nar\/gkh381","DOI":"10.1093\/nar\/gkh381"},{"key":"3548_CR48","unstructured":"Macromodel (2009) Schr\u00f6dinger, LLC, New York, NY"},{"key":"3548_CR49","unstructured":"LigPrep (2009) Schr\u00f6dinger, LLC, New York, NY"},{"key":"3548_CR50","unstructured":"Epik (2009) Schr\u00f6dinger, LLC, New York, NY"},{"key":"3548_CR51","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/jcc.20292","volume":"26","author":"JL Banks","year":"2005","unstructured":"Banks JL, Beard HS, Cao Y et al (2005) Integrated modeling program, applied chemical theory (IMPACT). J Comput Chem 26:1752\u20131780. \n                    https:\/\/doi.org\/10.1002\/jcc.20292","journal-title":"J Comput Chem"},{"key":"3548_CR52","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u20131749. \n                    https:\/\/doi.org\/10.1021\/jm0306430","journal-title":"J Med Chem"},{"key":"3548_CR53","doi-asserted-by":"publisher","first-page":"i262","DOI":"10.1093\/bioinformatics\/btw257","volume":"32","author":"S Basu","year":"2016","unstructured":"Basu S, Wallner B (2016) Finding correct protein-protein docking models using ProQDock. Bioinformatics 32:i262\u2013i270. \n                    https:\/\/doi.org\/10.1093\/bioinformatics\/btw257","journal-title":"Bioinformatics"},{"key":"3548_CR54","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1021\/acs.jcim.5b00745","volume":"56","author":"A Anighoro","year":"2016","unstructured":"Anighoro A, Bajorath J (2016) Three-dimensional similarity in molecular docking: prioritizing Ligand poses on the basis of experimental binding modes. J Chem Inf Model 56:580\u2013587. \n                    https:\/\/doi.org\/10.1021\/acs.jcim.5b00745","journal-title":"J Chem Inf Model"},{"key":"3548_CR55","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1021\/jm049092j","volume":"48","author":"N Triballeau","year":"2005","unstructured":"Triballeau N, Acher F, Brabet I et al (2005) Virtual screening workflow development guided by the \u201creceiver operating characteristic\u201d curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J Med Chem 48:2534\u20132547. \n                    https:\/\/doi.org\/10.1021\/jm049092j","journal-title":"J Med Chem"},{"key":"3548_CR56","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.patrec.2005.10.010","volume":"27","author":"T Fawcett","year":"2006","unstructured":"Fawcett T (2006) An introduction to ROC analysis. Pattern Recogn Lett 27:861\u2013874. \n                    https:\/\/doi.org\/10.1016\/j.patrec.2005.10.010","journal-title":"Pattern Recogn Lett"},{"key":"3548_CR57","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1471-2105-15-82","volume":"15","author":"CJ Bendell","year":"2014","unstructured":"Bendell CJ, Liu S, Aumentado-Armstrong T et al (2014) Transient protein-protein Interface prediction: datasets, features, algorithms, and the RAD-T predictor. BMC Bioinf 15:82. \n                    https:\/\/doi.org\/10.1186\/1471-2105-15-82","journal-title":"BMC Bioinf"},{"key":"3548_CR58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1471-2105-12-195","volume":"12","author":"S Basu","year":"2011","unstructured":"Basu S, Bhattacharyya D, Banerjee R (2011) Mapping the distribution of packing topologies within protein interiors shows predominant preference for specific packing motifs. BMC Bioinf 12:195. \n                    https:\/\/doi.org\/10.1186\/1471-2105-12-195","journal-title":"BMC Bioinf"},{"key":"3548_CR59","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jmb.2003.08.013","volume":"333","author":"R Banerjee","year":"2003","unstructured":"Banerjee R, Sen M, Bhattacharyya D et al (2003) The jigsaw puzzle model: search for conformational specificity in protein interiors. J Mol Biol Vol 333:211\u2013226. \n                    https:\/\/doi.org\/10.1016\/j.jmb.2003.08.013","journal-title":"J Mol Biol Vol"},{"key":"3548_CR60","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.2174\/138161210793176536","volume":"16","author":"C Galdeano","year":"2010","unstructured":"Galdeano C, Viayna E, Arroyo P et al (2010) Structural determinants of the multifunctional profile of dual binding site acetyl- cholinesterase inhibitors as anti-Alzheimer agents. Curr Pharm Des 16:2818\u20132836","journal-title":"Curr Pharm Des"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00894-017-3548-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-017-3548-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-017-3548-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T07:24:33Z","timestamp":1547450673000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00894-017-3548-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["3548"],"URL":"https:\/\/doi.org\/10.1007\/s00894-017-3548-9","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"21 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"41"}}